Skip to content
MARKETS / NASDAQ / SPAI
NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Safe Pro Group Inc. SPAI

3 fiscal years on record · USD · FY2025 reported · SEC filings only
$606,681
▼ 72.0% YoY
$-14.3M
$-6.3M
In brief

What this company does

Our core capabilities include artificial intelligence/machine learning, mission critical drone services and manufacturing of high performance ballistic protective products. Through our subsidiary, Safe-Pro USA LLC, we are a specialist in the manufacturer of ultra-premium bullet and blast resistant protection equipment utilized by domestic and international customers in the military, law enforcement, and humanitarian/peacekeeping markets. Through our subsidiary, Airborne Response Corp., we provide a wide range of contracted aerial platform-based technology services predominantly using small Uncrewed Aircraft Systems (“UAS”) — commonly referred to as “drones.” Safe Pro AI is a developer of patented artificial intelligence (“AI”), machine learning (“ML”) and computer vision systems technologies for the rapid processing and analysis of drone-based imagery.

Written from the business description in Safe Pro Group Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 31 March 2026. Every sentence was checked against that document before publication.

Growth
USD 606,681.00
Revenue, FY2025 · full 3-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.6 · Net income -14.3
0.8M1.6M-5.0M-10.0M202320242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−2361 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -2397.6% · Net -2360.8%
-1000%-2000%202320242025
ROE
FY2025 · ROE -132.7%
-100%-200%202320242025

Each USD of equity lost 133 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -6.3
-2.5M-5.0M202320242025

Total assetsUSD 19.1M
EquityUSD 17.7M
CashUSD 16.8M
Gross debtUSD 146,000.00
Net debtUSD -16.6M
Current ratio14.33×

The company holds more cash than debt.

The 3-year record
3 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023
Revenue $B0.00.00.0
Operating income $B−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0
Income tax $B···
Net income $B−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0
EPS, diluted $−0.85−0.70−0.79
Dividend / sh $···
Payout %···
ROE %−132.7−262.9−289.9
Shares out B0.020.010.01

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 16 reconciliationsAUDITED

Reconciled in 4 of 19 fiscal years. 79 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2022

Share this section

Download image